Review Article| Volume 25, ISSUE 2, P133-147, September 2017

Oral Complications of Nonsurgical Cancer Therapies

  • Sharon Elad
    Corresponding author.
    Department of Oral Medicine, Eastman Institute for Oral Health, University of Rochester Medical Center, 625 Elmwood Avenue, Rochester, NY 14620, USA
    Search for articles by this author
  • Yehuda Zadik
    Oral Medicine Clinic for Hematologic and Oncologic Patients, Department of Oral Medicine, Sedation and Maxillofacial Imaging, Hebrew University-Hadassah School of Dental Medicine, PO Box 91120, Jerusalem 9112102, Israel

    Department of Oral Medicine, Oral and Maxillofacial Center, Medical Corps, Israel Defense Forces, Military PO Box 02149, Tel Hashomer, Israel
    Search for articles by this author
  • Noam Yarom
    Oral Medicine Unit, Sheba Medical Center, Tel Hashomer, Israel

    Department of Oral Pathology and Oral Medicine, School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel
    Search for articles by this author
      There are a variety of nonsurgical cancer treatment modalities, such as chemotherapy, radiotherapy, hematopoietic stem cell transplantation, and targeted therapy.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


        • Watters A.L.
        • Epstein J.B.
        • Agulnik M.
        Oral complications of targeted cancer therapies: a narrative literature review.
        Oral Oncol. 2011; 47: 441-448
        • Vera-Llonch M.
        • Oster G.
        • Hagiwara M.
        • et al.
        Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma.
        Cancer. 2006; 106: 329-336
        • De Sanctis V.
        • Bossi P.
        • Sanguineti G.
        • et al.
        Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus statements.
        Crit Rev Oncol Hematol. 2016; 100: 147-166
        • Sonis S.T.
        Oral mucositis in head and neck cancer: risk, biology, and management.
        Am Soc Clin Oncol Educ book. 2013; : e236-e240
        • Elting L.S.
        • Cooksley C.
        • Chambers M.
        • et al.
        The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis.
        Cancer. 2003; 98: 1531-1539
        • Lalla R.V.
        • Bowen J.
        • Barasch A.
        • et al.
        MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
        Cancer. 2014; 120: 1453-1461
        • Elad S.
        • Zadik Y.
        Chronic oral mucositis after radiotherapy to the head and neck: a new insight.
        Support Care Cancer. 2016; 24: 4825-4830
        • Barrett A.P.
        Neutropenic ulceration. A distinctive clinical entity.
        J Periodontol. 1987; 58: 51-55
        • Hasturk H.
        • Tezcan I.
        • Yel L.
        • et al.
        A case of chronic severe neutropenia: oral findings and consequences of short-term granulocyte colony-stimulating factor treatment.
        Aust Dent J. 1998; 43: 9-13
        • Cheney-Peters D.
        • Lund T.C.
        Oral pyogenic granuloma after bone marrow transplant in the pediatric/adolescent population: report of 5 cases.
        J Pediatr Hematol Oncol. 2016; 38: 570-573
        • Kanda Y.
        • Arai C.
        • Chizuka A.
        • et al.
        Pyogenic granuloma of the tongue early after allogeneic bone marrow transplantation for multiple myeloma.
        Leuk Lymphoma. 2000; 37: 445-449
        • Lee W.J.
        • Lee J.L.
        • Chang S.E.
        • et al.
        Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
        Br J Dermatol. 2009; 161: 1045-1051
        • Martins F.
        • de Oliveira M.A.
        • Wang Q.
        • et al.
        A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients.
        Oral Oncol. 2013; 49: 293-298
        • Peterson D.E.
        • O'Shaughnessy J.A.
        • Rugo H.S.
        • et al.
        Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice.
        Cancer Med. 2016; 5: 1897-1907
        • Sonis S.
        • Treister N.
        • Chawla S.
        • et al.
        Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients.
        Cancer. 2010; 116: 210-215
        • Meleti M.
        • Vescovi P.
        • Mooi W.J.
        • et al.
        Pigmented lesions of the oral mucosa and perioral tissues: a flow-chart for the diagnosis and some recommendations for the management.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105: 606-616
        • Wong M.
        • Sade S.
        • Gilbert M.
        • et al.
        Oral melanosis after tyrosine kinase inhibition with Imatinib for chronic myelogenous leukemia: report of a case and review of the literature.
        Dermatol Online J. 2011; 17: 4
        • Resende R.G.
        • Teixeira R.G.
        • Vasconcelos Fde O.
        • et al.
        Imatinib-associated hyperpigmentation of the palate in post-HSCT patient.
        J Craniomaxillofac Surg. 2012; 40: e140-e143
        • Jensen S.B.
        • Pedersen A.M.
        • Vissink A.
        • et al.
        A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.
        Support Care Cancer. 2010; 18: 1039-1060
        • Wilberg P.
        • Hjermstad M.J.
        • Ottesen S.
        • et al.
        Chemotherapy-associated oral sequelae in patients with cancers outside the head and neck region.
        J Pain Symptom Manage. 2014; 48: 1060-1069
        • Chaushu G.
        • Itzkovitz-Chaushu S.
        • Yefenof E.
        • et al.
        A longitudinal follow-up of salivary secretion in bone marrow transplant patients.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995; 79: 164-169
        • Buchali A.
        • Feyer P.
        • Groll J.
        • et al.
        Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation.
        Radiother Oncol. 2000; 54: 157-162
        • Jensen S.B.
        • Pedersen A.M.
        • Vissink A.
        • et al.
        A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.
        Support Care Cancer. 2010; 18: 1061-1079
      1. AAOM Clinical Practice Statement: subject: clinical management of cancer therapy-induced salivary gland hypofunction and xerostomia.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 122: 310-312
        • Keshet N.
        • Abu-Tair J.
        • Zaharia B.
        • et al.
        Superficial oral mucoceles in cancer patient after radiation therapy: an overlooked yet imperative phenomenon.
        Oral Oncol. 2016; 52: e1-e2
        • De Felice F.
        • Musio D.
        • Tombolini V.
        Osteoradionecrosis and intensity modulated radiation therapy: an overview.
        Crit Rev Oncol Hematol. 2016; 107: 39-43
        • Peterson D.E.
        • Doerr W.
        • Hovan A.
        • et al.
        Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies.
        Support Care Cancer. 2010; 18: 1089-1098
        • Buglione M.
        • Cavagnini R.
        • Di Rosario F.
        • et al.
        Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.
        Crit Rev Oncol Hematol. 2016; 97: 131-142
        • Costa D.A.
        • Costa T.P.
        • Netto E.C.
        • et al.
        New perspectives on the conservative management of osteoradionecrosis of the mandible: a literature review.
        Head Neck. 2016; 38: 1708-1716
        • Yarom N.
        • Elad S.
        • Madrid C.
        • et al.
        Osteonecrosis of the jaws induced by drugs other than bisphosphonates - a call to update terminology in light of new data.
        Oral Oncol. 2010; 46: e1
        • Ruggiero S.L.
        • Dodson T.B.
        • Fantasia J.
        • et al.
        American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw–2014 update.
        J Oral Maxillofac Surg. 2014; 72: 1938-1956
        • Lazarovici T.S.
        • Yahalom R.
        • Taicher S.
        • et al.
        Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
        J Oral Maxillofac Surg. 2009; 67: 850-855
        • Yarom N.
        • Yahalom R.
        • Shoshani Y.
        • et al.
        Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.
        Osteoporos Int. 2007; 18: 1363-1370
        • Robbins K.T.
        Barriers to winning the battle with head-and-neck cancer.
        Int J Radiat Oncol Biol Phys. 2002; 53: 4-5
        • Russi E.G.
        • Corvo R.
        • Merlotti A.
        • et al.
        Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology.
        Cancer Treat Rev. 2012; 38: 1033-1049
        • Jacobi I.
        • van der Molen L.
        • Huiskens H.
        • et al.
        Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review.
        Eur Arch Otorhinolaryngol. 2010; 267: 1495-1505
        • Xi S.
        Effectiveness of voice rehabilitation on vocalisation in postlaryngectomy patients: a systematic review.
        Int J Evid Based Healthc. 2010; 8: 256-258
        • Zadik Y.
        Restricted mouth opening in chronic graft-versus-host disease.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 121: 201-202
        • Elad S.H.
        • Horowitz R.
        • Zadik Y.
        Supportive and palliative care in dentistry and oral medicine.
        in: Smith H.S. Pilitsis J.G. The art and science of palliative medicine. AME Publishing Company, Hong Kong (China)2014: 385-405
        • Hovan A.J.
        • Williams P.M.
        • Stevenson-Moore P.
        • et al.
        A systematic review of dysgeusia induced by cancer therapies.
        Support Care Cancer. 2010; 18: 1081-1087
        • Epstein J.B.
        • Smutzer G.
        • Doty R.L.
        Understanding the impact of taste changes in oncology care.
        Support Care Cancer. 2016; 24: 1917-1931
        • Yuan A.
        • Kurtz S.L.
        • Barysauskas C.M.
        • et al.
        Oral adverse events in cancer patients treated with VEGFR-directed multitargeted tyrosine kinase inhibitors.
        Oral Oncol. 2015; 51: 1026-1033
        • Hull K.M.
        • Kerridge I.
        • Schifter M.
        Long-term oral complications of allogeneic haematopoietic SCT.
        Bone Marrow Transplant. 2012; 47: 265-270
        • Zadik Y.
        • Vainstein V.
        • Heling I.
        • et al.
        Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain.
        J Endod. 2010; 36: 1588-1592
        • Deng J.
        • Jackson L.
        • Epstein J.B.
        • et al.
        Dental demineralization and caries in patients with head and neck cancer.
        Oral Oncol. 2015; 51: 824-831
        • Hong C.H.
        • Napenas J.J.
        • Hodgson B.D.
        • et al.
        A systematic review of dental disease in patients undergoing cancer therapy.
        Support Care Cancer. 2010; 18: 1007-1021
        • Castellarin P.
        • Stevenson K.
        • Biasotto M.
        • et al.
        Extensive dental caries in patients with oral chronic graft-versus-host disease.
        Biol Blood Marrow Transplant. 2012; 18: 1573-1579
        • Curtis Jr., J.W.
        • Caughman G.B.
        An apparent unusual relationship between rampant caries and the oral mucosal manifestations of chronic graft-versus-host disease.
        Oral Surg Oral Med Oral Pathol. 1994; 78: 267-272
        • Singh M.L.
        • Papas A.S.
        Long-term clinical observation of dental caries in salivary hypofunction patients using a supersaturated calcium-phosphate remineralizing rinse.
        J Clin Dent. 2009; 20: 87-92
        • Sim C.P.
        • Wee J.
        • Xu Y.
        • et al.
        Anti-caries effect of CPP-ACP in irradiated nasopharyngeal carcinoma patients.
        Clin Oral Investig. 2015; 19: 1005-1011
        • Gomes C.B.
        • Treister N.S.
        • Miller B.
        • et al.
        Pulp obliteration in a patient with sclerodermatous chronic graft-versus-host disease.
        J Endod. 2016; 42: 678-680
        • Epstein J.B.
        • Stevenson-Moore P.
        Periodontal disease and periodontal management in patients with cancer.
        Oral Oncol. 2001; 37: 613-619
        • Heimdahl A.
        • Nord C.E.
        Colonization of the oropharynx with pathogenic microorganisms–a potential risk factor for infection in compromised patients.
        Chemioterapia : Int J Mediterr Soc Chemother. 1985; 4: 186-191
        • Dreizen S.
        • Bodey G.P.
        • Valdivieso M.
        Chemotherapy-associated oral infections in adults with solid tumors.
        Oral Surg Oral Med Oral Pathol. 1983; 55: 113-120
        • Khan S.A.
        • Wingard J.R.
        Infection and mucosal injury in cancer treatment.
        J Natl Cancer Inst Monographs. 2001; : 31-36
        • Lalla R.V.
        • Latortue M.C.
        • Hong C.H.
        • et al.
        A systematic review of oral fungal infections in patients receiving cancer therapy.
        Support Care Cancer. 2010; 18: 985-992
        • Elad S.
        • Zadik Y.
        • Hewson I.
        • et al.
        A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea.
        Support Care Cancer. 2010; 18: 993-1006
        • Elad S.
        • Ranna V.
        • Ariyawardana A.
        • et al.
        A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions.
        Support Care Cancer. 2016; 25: 687-700
        • Singavi A.K.
        • Harrington A.M.
        • Fenske T.S.
        Post-transplant lymphoproliferative disorders.
        Cancer Treat Res. 2015; 165: 305-327
        • Elad S.
        • Meyerowitz C.
        • Shapira M.Y.
        • et al.
        Oral posttransplantation lymphoproliferative disorder: an uncommon site for an uncommon disorder.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105: 59-64
        • Curtis R.E.
        • Rowlings P.A.
        • Deeg H.J.
        • et al.
        Solid cancers after bone marrow transplantation.
        N Engl J Med. 1997; 336: 897-904
        • Curtis R.E.
        • Metayer C.
        • Rizzo J.D.
        • et al.
        Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study.
        Blood. 2005; 105: 3802-3811
        • Mawardi H.
        • Elad S.
        • Correa M.E.
        • et al.
        Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes.
        Bone Marrow Transplant. 2011; 46: 884-891
        • Bingol U.A.
        • Arslan H.
        • Cinar C.
        Postradiation sarcoma from a free flap.
        J Craniofac Surg. 2013; 24: 2160-2162
        • Bonetta A.
        • Gelli M.C.
        • Zini G.
        • et al.
        Postradiation sarcoma of head and neck: report of two cases.
        Tumori. 1996; 82: 270-272
        • Effinger K.E.
        • Migliorati C.A.
        • Hudson M.M.
        • et al.
        Oral and dental late effects in survivors of childhood cancer: a Children's Oncology Group report.
        Support Care Cancer. 2014; 22: 2009-2019
        • van der Pas-van Voskuilen I.G.
        • Veerkamp J.S.
        • Raber-Durlacher J.E.
        • et al.
        Long-term adverse effects of hematopoietic stem cell transplantation on dental development in children.
        Support Care Cancer. 2009; 17: 1169-1175
        • Bensadoun R.J.
        • Riesenbeck D.
        • Lockhart P.B.
        • et al.
        A systematic review of trismus induced by cancer therapies in head and neck cancer patients.
        Support Care Cancer. 2010; 18: 1033-1038
        • Meier J.K.
        • Wolff D.
        • Pavletic S.
        • et al.
        Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD.
        Clin Oral Investig. 2011; 15: 127-139
        • Carpenter P.A.
        • Kitko C.L.
        • Elad S.
        • et al.
        National Institutes of Health consensus development Project on Criteria for clinical Trials in chronic graft-versus-host disease: V. The 2014 ancillary therapy and supportive care Working group report.
        Biol Blood Marrow Transplant. 2015; 21: 1167-1187
        • Rhodus N.L.
        Cancer and oral care of the cancer patient.
        in: Little J.W. Falace D.A. Miller C.S. Dental management of the medically compromised patient. 8th edition. Elsevier Mosby, St Louis (MO)2013: 459-492
        • Peterson D.B.
        • Jensen S.B.
        Oral complications of nonsurgical cancer therapies: diagnosis and treatment.
        in: Glick M. Burket’s oral medicine. 12th edition. People’s Medical Publishing House, Shelton (CT)2015: 201-218